Oracle Analysts Boost Their Forecasts After Strong Q4 Results

Oracle Corporation (NYSE: ORCL) reported better-than-expected results for its fourth quarter on Monday.

Oracle Corporation (NYSE:ORCL) reported better-than-expected results for its fourth quarter on Monday.

Oracle said fourth-quarter revenue increased 17% year-over-year to $13.8 billion which beat average analyst estimates of $13.73 billion. The company reported quarterly adjusted earnings of $1.67 per share, which beat consensus estimates of $1.58 per share.

Oracle's board declared a quarterly cash dividend of 40 cents per share.

Oracle shares rose 5.6% to $122.89 in today’s pre-market trading session.

These analysts made changes to their price targets on Oracle following earnings announcement.

  • BMO Capital raised the price target on Oracle from $96 to $132. BMO Capital analyst Keith Bachman maintained a Market Perform rating.
  • UBS increased the price target on Oracle from $110 to $120. UBS analyst Karl Keirstead maintained a Neutral rating.
  • Guggenheim boosted Oracle price target from $120 to $150. Guggenheim analyst John Difucci maintained a Buy rating.
  • Goldman Sachs analyst Kash Rangan, meanwhile, upgraded Oracle from Sell to Neutral and announced a $120 price target.

 

Read This Next: Manchester United, Oracle And 3 Stocks To Watch Heading Into Tuesday

Total
0
Shares
Related Posts
Read More

Why Smart For Life Stock Is Racing Higher

Smart for Life will acquire Purely Optimal Nutrition, an eCommerce nutraceuticals company with operations in North America. The company expects the acquisition deal to close within the next eight weeks. "This acquisition is another validation of our ‘Buy-and-Build' strategy designed to establish Smart for Life as a major international force in the Health & Wellness sector," stated Darren Minton, CEO of Smart for Life.

SMFL